BFLY · Butterfly Network Inc
Price
Snapshot
50 fields · last close| Market Cap | $2.20B |
| P/E | — |
| Float | 209.7M |
| Beta | 2.09 |
| Volatility | 52.1% |
| Exchange | NYSE |
| Sector | Health Care |
| Cap tier | Mid cap |
| Macro sensitivity | Very High |
| Clavix score | 25.0 |
| Price | 7.82 |
| Change | −3.46% |
| Prev Close | 8.10 |
| Open | 8.50 |
| Day Low | 8.01 |
| Day High | 8.51 |
| Avg Vol | 6 |
| Avg $ Vol | $47.07M |
| 52W High | 10.21 |
| 52W Low | 1.90 |
| 52W Pos | 71.2% |
| From High | −23.41% |
| From Low | +311.58% |
| Max DD 1Y | −40.61% |
| Spread | 0.10% |
| Liquidity | Normal |
| SMA 20 | −9.67% |
| SMA 50 | −8.30% |
| SMA 200 | +33.92% |
| RSI (14) | 46.1 |
| Vol 30D | 92.0% |
| Vol 90D | 121.6% |
| 1Y Range | 2–10 |
| Daily bars | 900 |
| Perf Week | −6.90% |
| Perf Month | +9.31% |
| Perf Quarter | +10.96% |
| Perf Half Y | +82.43% |
| Perf Year | +255.26% |
| Perf YTD | +108.53% |
| Prev Day | −3.46% |
| Clavix | F |
| Debt / Eq | 0.00 |
| Curr Ratio | 3.83 |
| Int Cover | — |
| FCF Margin | −16.4% |
| Rev Growth | +19.0% |
| Profit | Unprofitable |
| Leverage | Low |
| Sector rank | 49 / 49 |
Clavix risk grade
regraded every trading dayBFLY grades F, 25.0 of 100. Steadiest on Sector Resilience (69), most exposed on Price Stability (2, weak). 1 of the 4 weighted dimensions sit above the Health Care median. Ranks 49 of 49 in Health Care by Clavix score.
How rough the ride is
| BFLY | Health Care median | |
|---|---|---|
| Betavs the overall market · lower is steadier | 2.09 | 0.85 |
| Volatilityannualized | 52.1% | 21.3% |
| Max drawdown, past yearworst peak-to-trough fall | −40.6% | — |
| Typical daily movemedian absolute daily change | 3.34% | — |
| Days beyond ±3%of the last 252 sessions | 141 (56%) | — |
How its days are spread
Daily returns over the last 252 sessions in 1% bins. Moves beyond ±6% land in the end bins.
52-week range
The bar runs from the lowest to the highest close of the last 252 sessions; the marker is the latest close.
Drawdown from the 1-year peak
Percent below the running high over the last 12 months. Zero is a fresh high.
Market sensitivity
| BFLY | Health Care median | |
|---|---|---|
| Beta to the markethow much it swings with the S&P 500 · lower is safer | 2.09 | 0.85 |
| Macro sensitivityrate, dollar and credit exposure bucket | Very High | Moderate 53% of 49 |
Where it sits on the macro scale
Low means rates, the dollar and credit spreads barely move it. Very High means they drive a large share of its swings. The counts are how many Health Care names sit in each bucket.
Where it ranks in its sector
Rank by Clavix score within the sector. Right is the top of the sector.
Price performance
| BFLY | |
|---|---|
| 1 week | −6.9% |
| 1 month | +9.3% |
| Year to date | +108.5% |
| 1 year | +255.3% |
Context for the rank, not itself a risk measure.
Recent coverage, scored
| BFLY | |
|---|---|
| Articles scoredthe most recent scored coverage, up to 30 | 17 since 15 Sep |
| Average score0 most bearish, 100 most bullish | 63 |
| Bullish · bearisharticles above 60 · below 40 | 12 · 2 |
| Directionarticles whose tone is improving vs worsening | 12 ↑ 2 ↓ |
Where the article scores land
Each bar is a 10-point band of article scores. Below 40 reads bearish, above 60 bullish.
Balance sheet, against the sector
The shaded band is the middle half of the 49 Health Care names Clavix covers; the tick is the sector median.
Growth
| BFLY | |
|---|---|
| Revenue growthyear over year | +19.0% |
Financial Health is shown but does not count toward the grade. Why
0–100, higher is safer. The tick on each bar is the Health Care median. Click a dimension for the evidence behind it. Financial Health is shown but does not count toward the grade.
Recent news
most recent scored articles · the chip is the article’s score · click to openButterfly Network (BFLY) said it will report Q3 2026 financial results on Oct. 29, 2026 at 8:00 a.m. ET, with CEO Joseph DeVivo and CFO John Doherty hosting a pre-market call and webcast. The announcement highlights Butterfly’s platform strategy spanning Ultrasound-on-Chip hardware (including the third-generation iQ3), cloud software, AI workflows (Compass AI), and its Butterfly Embedded licensing business.
Zimmer Biomet (NYSE:ZBH - Get Free Report) and Butterfly Network (NYSE:BFLY - Get Free Report) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, analyst recommendations, profitability, earnings and valuation. Risk & Volatility Zimmer Biomet has a beta […]
Butterfly Network CEO Joseph DeVivo sold 35,790 shares on October 6th at an average price of $10.02, for about $358,616. After the sale, he still directly owned roughly 7.3 million shares worth about $73.3 million, and the sale trimmed his position by 0.49%. The sale was made under a pre-arranged trading plan (a 10b5-1 plan), which is a schedule an insider sets up in advance so they can sell shares on fixed dates without being accused of trading on inside information.
BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, announced that it will report third quarter 2026 financial results on Thursday, October 29, 2026, at 8:00 am ET. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and John Doherty, Executive Vice President and Chief Financial Officer, will host a conference call and webcas
Why Butterfly Network’s Bridge Neurotech Deal Matters Now Butterfly Network (BFLY) just signed a multi-year research and development agreement with Bridge Neurotech that puts its Ultrasound-on-Chip technology at the center of fully non-invasive brain-computer interface work. The arrangement includes licensing fees for Butterfly’s ultrasound platform, milestone-based payments over time, and hardware purchase commitments. This structure gives investors clearer visibility into how the embedded...
Nearest peers by size
Health Care| Ticker | Company | Grade | Mkt cap | P/E | Beta | |
|---|---|---|---|---|---|---|
| ACHC | Acadia Healthcare Company Inc | B- | $2.81B | — | 0.64 | Compare |
| CRVL | CorVel Corp | B+ | $3.98B | 34.54 | 1.10 | Compare |
| RDNT | RadNet Inc | B | $5.63B | — | 1.43 | Compare |
| HIMS | Hims & Hers Health Inc | D- | $6.93B | 54.00 | 2.51 | Compare |
| HNGE | Hinge Health Inc | C+ | $8.48B | 77.79 | 1.51 | Compare |
| HSIC | Henry Schein Inc | A- | $9.48B | 23.32 | 0.86 | Compare |
| PODD | Insulet Corp | B- | $9.58B | 26.01 | 1.09 | Compare |
| GKOS | Glaukos Corp | B | $9.76B | — | 0.73 | Compare |
You just read one holding. Clavix reads the whole portfolio.
Every position you own, graded on the same five dimensions, with an alert when a grade moves. Three months free on iPhone.